다운로드 Symptom to Diagnosis EB Guide PC 용

PC를 설정하고 Windows 11에서 Symptom to Diagnosis EB Guide 앱을 다운로드하는 단계:

1. 컴퓨터가 호환되는지 확인: 최소 요구 사항은 다음과 같습니다.
• RAM: 8GB (최저한의), 16GB (추천)
• 저장: SSD
• Processor:
• Intel Core i3 8th Gen (최소 이상)
• AMD Ryzen 3000 (최소 이상)
• Qualcomm Snapdragon 8c (최소 이상)
• Processor Architecture: x64 or ARM64
2. Symptom to Diagnosis EB Guide 에 이미 기본 Windows 버전이 있는지 확인하십시오. 여기서 하세요 ». 기본 버전이 없으면 3단계로 진행합니다.

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. Symptom to Diagnosis aims to help students and residents learn internal medicine and focuses on the challenging task of diagnosis. Learn the diagnostic process in internal medicine with this engaging, case-based approach. "This book is a tremendous asset for students and residents learning to develop their diagnostic skills. It can also be useful as a refresher for established clinicians when the more common diagnoses are not the cause of a patient's complaints."―Doody's Review An engaging case-based approach to learning the diagnostic process in internal medicine Doody's Core Titles for 2021! Symptom to Diagnosis, the latest edition teaches an evidence-based, step-by-step process for evaluating, diagnosing, and treating patients based on their clinical complaints. By applying this process clinicians will be able to recognize specific diseases and prescribe the most effective therapy. Each chapter is built around a common patient complaint that illustrates essential concepts and provides insight into the process by which the differential diagnosis is identified. As the case progresses, clinical reasoning is explained in detail. The differential diagnosis for that particular case is summarized in tables that highlight the clinical clues and important tests for the leading diagnostic hypothesis and alternative diagnostic hypotheses. As the chapter progresses, the pertinent diseases are reviewed. Just as in real life, the case unfolds in a stepwise fashion as tests are performed and diagnoses are confirmed or refuted. Completely updated to reflect the latest research in clinical medicine, this fourth edition is enhanced by algorithms, summary tables, questions that direct evaluation, and an examination of recently developed diagnostic tools and guidelines. Clinical pearls are featured in every chapter. Coverage for each disease includes: Textbook Presentation, Disease Highlights, Evidence-Based Diagnosis, and Treatment. Changes include new algorithms and approaches in the chapters on Chest Pain, Syncope, Dizziness, and others. Recently developed new diagnostic tools are discussed in the chapters of Diarrhea, Jaundice, and Cough and Fever, and new guidelines have been included in the chapters on Screening, Diabetes, and Hypertension Content licensed from printed edition ISBN 10: 1260121119 Content licensed from printed edition ISBN 13: 978-1260121117 SUBSCRIPTION : Please choose an auto renewable subscription plan to receive content access and continuous updates. Your subscription automatically renews as per your plan, so you always have the latest content. Six months auto-renewing payments - $29.99 Yearly auto-renewing payments- $49.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s): Scott D. C. Stern, MD, FACP; Adam S. Cifu, MD, FACP; Diane Altkorn, MD, FACP Publisher: The McGraw-Hill Companies, Inc.